Contraceptive Access Change Package

This quality improvement tool was designed to support Title X grantees’ performance improvement on two National Quality Forum-endorsed contraceptive care measures:

• Most and moderately effective methods: Percentage of women aged 15-44 years at risk of unintended pregnancy that is provided a most effective (i.e., male or female sterilization, implants, intrauterine devices/systems or moderately effective (i.e., injectables, oral pills, patch, ring or diaphragm) method of contraception
• Access to long-acting reversible contraceptive (LARC) method: Percentage of women aged 15-44 years at risk of unintended pregnancy that is provided a LARC method (i.e., implants, intrauterine devices/systems

The package includes a rationale, improvement strategies, and Title X success stories for four best practices.

Note: This resource is under review due to a recent change in guidance. LNG-IUD 52mg is now approved to prevent pregnancy for up to 8 years.